Antigen specificity of clonally-enriched CD8+ T cells in multiple sclerosis

Kristen Mittl,Fumie Hayashi,Ravi Dandekar,Ryan D Schubert,Josiah Gerdts,Lindsay Oshiro,Rita Loudermilk,Ariele Greenfield,Danillo G Augusto,Akshaya Ramesh,Edwina Tran,Kaniskha Koshal,Kerry Kizer,Joanna Dreux,Alaina Cagalingan,Florian Schustek,Lena Flood,Tamson Moore,Lisa L Kirkemo,Tiffany Cooper,Meagan Harms,Refujia Gomez,University of California, San Francisco MS-EPIC Team,Leah Sibener,Bruce A C Cree,Stephen L Hauser,Jill A Hollenbach,Marvin Gee,Michael R Wilson,Scott S Zamvil,Joseph J Sabatino
DOI: https://doi.org/10.1101/2024.09.07.611010
2024-10-17
bioRxiv
Abstract:CD8+ T cells are the dominant lymphocyte population in multiple sclerosis (MS) lesions where they are highly clonally expanded. The clonal identity, function, and antigen specificity of CD8+ T cells in MS are not well understood. Here we report a comprehensive single-cell RNA-seq and T cell receptor (TCR)-seq analysis of the cerebrospinal fluid (CSF) and blood from a cohort of treatment-naïve MS patients and control participants. A small subset of highly expanded and activated CD8+ T cells were enriched in the CSF in MS that displayed high activation, cytotoxicity and tissue-homing transcriptional profiles. Using a combination of unbiased and targeted antigen discovery approaches, MS-derived CD8+ T cell clonotypes recognizing Epstein-Barr virus (EBV) antigens and multiple novel mimotopes were identified. These findings shed vital insight into the role of CD8+ T cells in MS and pave the way towards disease biomarkers and therapeutic targets.
What problem does this paper attempt to address?